This compound is a pharmaceutical intermediate used in the manufacturing of trilaciclib. It features a tert-butyl carbamate group linked to a cyclohexylamine moiety bearing a bromo-chloropyrimidine substituent.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1374635-87-6
7-(1-(((Tert-butoxycarbonyl)amino)methyl)cyclohexyl)-2-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid
Pharmaceutical intermediate for trilaciclib
Trilaciclib Impurity 36
pharmaceutical intermediate synthesis
(2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol
Pharmaceutical intermediate
Tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical intermediate for synthesis
TERT-BUTYL (2R,3R)-3-AMINO-2-METHYLPYRROLIDINE-1-CARBOXYLATE
Pharmaceutical intermediate
tert-butyl N-[[1-[(5-bromo-2-chloropyrimidin-4-yl)amino]cyclohexyl]methyl]carbamate
GPCHFSKUUKKXAN-UHFFFAOYSA-N
CC(C)(C)OC(=O)NCC1(CCCCC1)NC2=NC(=NC=C2Br)Cl
—